SARAH JACOBS: Open Payments
NPI 1063119758 · MIAMISBURG, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$940 in 55 payments from 12 companies in 2025. Trend: 2023 $980 · 2024 $1,264 · 2025 $940
Food & beverage: $940
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 32 | $449 |
| Axsome Therapeutics, Inc. | 5 | $132 |
| Supernus Pharmaceuticals, Inc. | 5 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Otsuka America Pharmaceutical, Inc. | 3 | $50 |
| Janssen Pharmaceuticals, Inc | 1 | $31 |
| Almatica Pharma LLC | 1 | $27 |
| Biogen, Inc. | 1 | $25 |
| Neurocrine BioSciences, Inc. | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $21 |
Products named: VRAYLAR, Auvelity, Qelbree, CAPLYTA, SPRAVATO, REXULTI, LOREEV XR, ZURZUVAE.
Industry payments across OH — which companies pay providers there.
